MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer
Bitencourt, Almir G.V., Gibbs, Peter, Rossi Saccarelli, Carolina, Daimiel, Isaac, Lo Gullo, Roberto, Fox, Michael J., Thakur, Sunitha, Pinker, Katja, Morris, Elizabeth A., Morrow, Monica, Jochelson, MVolume:
61
Journal:
EBioMedicine
DOI:
10.1016/j.ebiom.2020.103042
Date:
November, 2020
File:
PDF, 682 KB
2020